Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Hepatology International
Published in: Hepatology International 3/2015

01-07-2015 | Editorial

20-year survival post-liver transplant: much more is needed!

Authors: Russell Strong, Jonathan Fawcett

Published in: Hepatology International | Issue 3/2015

Login to get access

Excerpt

The manuscript entitled "Analysis of adult 20-year survivors after liver transplantation [1]" from a single centre in Barcelona, Spain, assessed the outcome and liver function of survivors 20 years after liver transplantation, together with the cause of death in those who did not survive to reach this milestone. There were 132 adult patients who received 151 liver transplants from deceased donors. During the first year, there were 41 recipients who died, with a further 41 deaths by 5 years and a further 22 who had succumbed by 20 years, leaving only 28 patients (21 %), approximately one in five of the recipients surviving to 20 years. …
Literature
1.
Dopazo C, Bilbao I, Castells L, Sapisochin G, Moreiras C, Campos-Varela I, et al. Analysis of adult 20-year survivors after liver transplantation. Hepatol Int 2015. doi:10.​1007/​s12072-014-9577-x
2.
Jain A, Reyes J, Kashyap R, Doson F, Demetris J, Ruppert K, et al. Long term survival after liver transplantation in 4,000 consecutive patients at a single center. Ann Surg 2000;232:490–500PubMedCentralPubMedCrossRef
3.
Jain A, Singhal A, Fontes P, Mazariegos G, DeVera M, Cacciarelli T, et al. One thousand consecutive primary liver transplants under tacrolimus immunosuppression: a 17–20 year longitudinal follow-up. Transplantation. 2011;91:1025–1030PubMedCrossRef
4.
Duffy J, Kao K, Ko C, Farmer D, McDiarmid S, Hing J, et al. Long-term patient outcome and quality of life after liver transplantation. Ann Surg 2010;252:652–661PubMed
5.
Agopian V, Petrowsky H, Kaldas F, Zarringpar A, Farmer D, Yersig H, et al. The evolution of liver transplantation during 3 decades. Ann Surg 2013;258:33–45CrossRef
6.
Schoening W, Buescher N, Rademacher S, Andreou A, Kuehn S, Neuhaus R, et al. Twenty-year longitudinal follow-up after orthotopic liver transplantation: a single-center experience of 313 consecutive cases. Am J Transpl 2013;13:2384–2394CrossRef
7.
Adam R, Karam V, Delvart V, O’Grady J, Mirza D, Klempnauer J, et al. Evolution of indications and results of liver transplantation in Europe. J Hepatol 2012;57:675–688PubMedCrossRef
8.
9.
Kelly D, Bucuvalas J, Alonso E, Karpen S, Allen U, Green M, et al. Long-term medical management of the pediatric patient after liver transplantation. Liver Transpl 2013;19:798–825PubMedCrossRef
Metadata
Title
20-year survival post-liver transplant: much more is needed!
Authors
Russell Strong
Jonathan Fawcett
Publication date
01-07-2015
Publisher
Springer India
Published in
Hepatology International / Issue 3/2015
Print ISSN: 1936-0533
Electronic ISSN: 1936-0541
DOI
https://doi.org/10.1007/s12072-015-9617-1

Other articles of this Issue 3/2015

Hepatology International 3/2015 Go to the issue

Editorial

Twenty-year survival post-liver transplant: challenges and lessons

Review Article

Anti-viral therapy in hepatitis B virus reactivation with acute-on-chronic liver failure

Review Article

A review of the burden of hepatitis C virus infection in China, Japan, South Korea and Taiwan

Review Article

Pattern and profile of chronic liver disease in acute on chronic liver failure

Review Article

The gut microbiota of nonalcoholic fatty liver disease: current methods and their interpretation

Review Article

Twist in hepatocellular carcinoma: pathophysiology and therapeutics
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits